Company · CIK 0001821586 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MoonLake Immunotherapeutics · MLTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 SForm 4 → | Jul 29, 4:10 pm EDT | Kristian ReichChief Scientific Officer | 1,100 | $20.00 | $22,000 | 2,711,198 | −0.04% | 10b5-1 |
| Jul 21, 2026 SForm 4 → | Jul 23, 4:05 pm EDT | Kristian ReichChief Scientific Officer | 52,448 | $20.02 | $1,049,960 | 2,712,298 | −1.90% | 10b5-1 |
| Jul 20, 2026 SForm 4 → | Jul 21, 6:13 pm EDT | Kristian ReichChief Scientific Officer | 43,700 | $20.09 | $877,933 | 2,764,746 | −1.56% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 20, 6:07 am EDT | Kristian ReichChief Scientific Officer | 16,105 | $20.01 | $322,261 | 2,808,446 | −0.57% | 10b5-1 late |
| Jul 9, 2026 SForm 4 → | Jul 13, 4:10 pm EDT | da Silva Jorge SantosChief Executive Officer, Director | 102,225 | $20.02 | $2,046,205 | 2,774,893 | −3.55% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:10 pm EDT | da Silva Jorge SantosChief Executive Officer, Director | 47,775 | $20.03 | $956,933 | 2,877,118 | −1.63% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.